טוען...
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds
V-RAF murine sarcoma viral oncogene homolog B1 (BRAF) is a serine/threonine-specific protein kinase that is mutated with high frequency in cutaneous melanoma, and many other cancers. Inhibition of mutant BRAF is an attractive therapeutic approach for the treatment of melanoma. A triarylimidazole BRA...
שמור ב:
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Elsevier Science
2010
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2956513/ https://ncbi.nlm.nih.gov/pubmed/20667740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2010.06.031 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|